Association Between Single-Nucleotide Polymorphisms in Breast Cancer Susceptibility Genes and Clinicopathological Characteristics

References

• Zheng RS, Sun KX, Zhang SW, et al. Report of cancer epidemiology in China, 2015. Zhonghua Zhong Liu Za Zhi. 2019;41(1):19–28. doi:10.3760/cma.j.issn.0253-3766.2019.01.00530678413
   PubMedGoogle Scholar
• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020;70(1):7–30. doi:10.3322/caac.2159031912902
   PubMed Web of Science ®Google Scholar
• Couch FJ, Hart SN, Sharma P, et al. Inherited mutations in 17 breast cancer susceptibility genes among a large triple-negative breast cancer cohort unselected for family history of breast cancer. J Clin Oncol. 2015;33(4):304–311. doi:10.1200/JCO.2014.57.141425452441
   PubMed Web of Science ®Google Scholar
• Robson M, Im SA, Senkus E, et al. Olaparib for metastatic breast cancer in patients with a germline BRCA mutation. N Engl J Med. 2017;377(6):523–533. doi:10.1056/NEJMoa170645028578601
   PubMed Web of Science ®Google Scholar
• Han W, Kang D, Park IA, et al. Associations between breast cancer susceptibility gene polymorphisms and clinicopathological features. Clin Cancer Res. 2004;10:124–130. doi:10.1158/1078-0432.CCR-0834-314734460
   PubMed Web of Science ®Google Scholar
• Garcia-Closas M, Hall P, Nevanlinna H, et al. Heterogeneity of breast cancer associations with five susceptibility loci by clinical and pathological characteristics. PLoS Genet. 2008;4(4):e1000054. doi:10.1371/journal.pgen.100005418437204
   PubMed Web of Science ®Google Scholar
• Slattery ML, John EM, Stern MC, et al. Associations with growth factor genes (FGF1, FGF2, PDGFB, FGFR2, NRG2, EGF, ERBB2) with breast cancer risk and survival: the breast cancer health disparities study. Breast Cancer Res Treat. 2013;140(3):587–601. doi:10.1007/s10549-013-2644-523912956
   PubMed Web of Science ®Google Scholar
• O’Brien KM, Cole SR, Engel LS, et al. Breast cancer subtypes and previously established genetic risk factors: a bayesian approach. Cancer Epidemiol Biomarkers Prev. 2014;23(1):84–97. doi:10.1158/1055-9965.EPI-13-046324177593
   PubMed Web of Science ®Google Scholar
• Chen FY, Wang H, Li H, et al. Association of single-nucleotide polymorphisms in monoubiquitinated FANCD2-DNA damage repair pathway genes with breast cancer in the Chinese population. Technol Cancer Res Treat. 2018;17:1–11. doi:10.1177/1533033818819841
   Web of Science ®Google Scholar
• Tang LL, Chen FY, Wang H, et al. Haplotype analysis of eight genes of the monoubiquitinated FANCD2-DNA damage-repair pathway in breast cancer patients. Cancer Epidemiol. 2013;37(3):311–317. doi:10.1016/j.canep.2012.12.01023357080
   PubMed Web of Science ®Google Scholar
• WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet. 2004;363:157–163. doi:10.1016/S0140-6736(03)15268-314726171
   PubMed Web of Science ®Google Scholar
• Goldhirsch A, Winer EP, Coates AS, et al.; Panel members. Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the primary therapy of early breast cancer 2013. Ann Oncol. 2013;24(9):2206–2223. doi:10.1093/annonc/mdt30323917950
   PubMed Web of Science ®Google Scholar
• Chen FY, Ou HY, Wang SM, Wu YH, Yan GJ, Tang LL. Associations between body mass index and molecular subtypes as well as other clinical characteristics of breast cancer in Chinese women. Ther Clin Risk Manag. 2013;9:131–137. doi:10.2147/TCRM.S4120323576872
   PubMed Web of Science ®Google Scholar
• Anoushirvani AA, Aghabozorgi R, Ahmadi A, et al. Association of rs1042522 SNP with clinicopathologic factors of breast cancer patients in the Markazi Province of Iran. Open Access Maced J Med Sci. 2018;6(12):2277–2282. doi:10.3889/oamjms.2018.48630607176
   PubMedGoogle Scholar
• Al-Eitan LN, Rababa’h DM, Alghamdi MA, Khasawneh RH. Correlation between candidate single nucleotide variants and several clinicopathological risk factors related to breast cancer in Jordanian women: a genotype-phenotype study. J Cancer. 2019;10(19):4647–4654. doi:10.7150/jca.3385731528229
   PubMed Web of Science ®Google Scholar
• Hao W, Xu X, Shi H, Zhang C, Chen X. No association of TP53 codon 72 and intron 3 16-bp duplication polymorphisms with breast cancer risk in Chinese Han women: new evidence from a population-based case-control investigation. Eur J Med Res. 2018;23(1):47. doi:10.1186/s40001-018-0345-630309383
   PubMed Web of Science ®Google Scholar
• Afzaljavan F, Chaeichi Tehrani N, Rivandi M, et al. The dilemma of TP53 codon 72 polymorphism (rs1042522) and breast cancer risk: a case-control study and meta-analysis in the Iranian population. Cell J. 2020;22(2):185–192. doi:10.22074/cellj.2020.645831721533
   PubMed Web of Science ®Google Scholar
• Schildkraut JM, Iversen ES, Wilson MA, et al. Association between DNA damage response and repair genes and risk of invasive serous ovarian cancer. PLoS One. 2010;5(4):e10061. doi:10.1371/journal.pone.001006120386703
   PubMed Web of Science ®Google Scholar
• Walsh T, King MC. Ten genes for inherited breast cancer. Cancer Cell. 2007;11(2):103–105. doi:10.1016/j.ccr.2007.01.01017292821
   PubMed Web of Science ®Google Scholar
• Wang J, Li W, Shi Y, et al. Germline mutation landscape of Chinese patients with familial breast/ovarian cancer in a panel of 22 susceptibility genes. Cancer Med. 2019;8(5):2074–2084. doi:10.1002/cam4.209330982232
   PubMed Web of Science ®Google Scholar
• Pan JW, Zabidi MMA, Ng PS, et al. The molecular landscape of Asian breast cancers reveals clinically relevant population-specific differences. Nat Commun. 2020;11(1):6433. doi:10.1038/s41467-020-20173-533353943
   PubMed Web of Science ®Google Scholar